Table 2.
Parameters | CLT (n = 168) | non-CLT (n = 337) | P |
---|---|---|---|
Sex | 146 (86.90%) F 22 (13.09%) M |
253 (75.07%) F 84 (24.93%) M |
0.002 |
F:M | 6.64:1 | 3.01:1 | – |
Age (m ± SD) | 44.42 ± 13.72 | 47.21 ± 13.76 | 0.03 |
Histotype | 76 (45.23%) classic variant 65 (38.69%) follicular variant 16 (9.52%) sclerosing 3 (1.80%) tall cell 6 (3.57%) Warthin-like 2 (1.19%) hobnail/micropapillary 0 cribriform |
180 (53.41%) classic variant 118 (35.01%) follicular variant 23 (6.82%) sclerosing 6 (1.78%) tall cell 3 (0.89%) Warthin-like 6 (1.78%) hobnail/micropapillary 1 cribriform (0.31%) |
0.22 |
Lymph node | 147 (87.5%) N0 21 (12.5%) N+ |
263 (78.04%) N0 74 (21.96%) N+ |
0.01 |
pT | 110 (65.47%) T1a 38 (22.61%) T1b 12 (7.16%) T2 8 (4.76%) T3 0 T4 |
168 (49.85%) T1a 67 (19.88%) T1b 22 (6.52%) T2 79 (23.44%) T3 1 (0.31%) T4 |
<0.0001 |